These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 32234404

  • 1. Calcinosis Biomarkers in Adult and Juvenile Dermatomyositis.
    Chung MP, Richardson C, Kirakossian D, Orandi AB, Saketkoo LA, Rider LG, Schiffenbauer A, von Mühlen CA, Chung L, International Myositis Assessment, Clinical Studies Group (IMACS) Calcinosis Scientific Interest Group.
    Autoimmun Rev; 2020 Jun; 19(6):102533. PubMed ID: 32234404
    [Abstract] [Full Text] [Related]

  • 2. Calcinosis in Juvenile Dermatomyositis-Epidemiology, Pathogenesis, Clinical Features, and Treatment: A Systematic Review.
    Gonçalves Júnior J, Shinjo SK.
    Curr Rheumatol Rep; 2024 Feb; 26(2):53-68. PubMed ID: 38060107
    [Abstract] [Full Text] [Related]

  • 3. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
    Vignesh P, Barman P, Basu S, Mondal S, Ishran B, Kumrah R, Dod A, Garg R, Rawat A, Singh S.
    Immunol Res; 2023 Feb; 71(1):112-120. PubMed ID: 36278969
    [Abstract] [Full Text] [Related]

  • 4. Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis.
    Duvvuri B, Pachman LM, Hermanson P, Wang T, Moore R, Ding-Hwa Wang D, Long A, Morgan GA, Doty S, Tian R, Sancak Y, Lood C.
    J Autoimmun; 2023 Jul; 138():103061. PubMed ID: 37244073
    [Abstract] [Full Text] [Related]

  • 5. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity.
    Bingham A, Mamyrova G, Rother KI, Oral E, Cochran E, Premkumar A, Kleiner D, James-Newton L, Targoff IN, Pandey JP, Carrick DM, Sebring N, O'Hanlon TP, Ruiz-Hidalgo M, Turner M, Gordon LB, Laborda J, Bauer SR, Blackshear PJ, Imundo L, Miller FW, Rider LG, Childhood Myositis Heterogeneity Study Group.
    Medicine (Baltimore); 2008 Mar; 87(2):70-86. PubMed ID: 18344805
    [Abstract] [Full Text] [Related]

  • 6. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.
    Walling HW, Gerami P, Sontheimer RD.
    Paediatr Drugs; 2010 Mar; 12(1):23-34. PubMed ID: 20034339
    [Abstract] [Full Text] [Related]

  • 7. The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.
    Hoeltzel MF, Oberle EJ, Robinson AB, Agarwal A, Rider LG.
    Curr Rheumatol Rep; 2014 Dec; 16(12):467. PubMed ID: 25366934
    [Abstract] [Full Text] [Related]

  • 8. Calcinosis in dermatomyositis: Origins and possible therapeutic avenues.
    Davuluri S, Duvvuri B, Lood C, Faghihi-Kashani S, Chung L.
    Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101768. PubMed ID: 35803868
    [Abstract] [Full Text] [Related]

  • 9. Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.
    Wienke J, Deakin CT, Wedderburn LR, van Wijk F, van Royen-Kerkhof A.
    Front Immunol; 2018 Jun; 9():2951. PubMed ID: 30619311
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.
    Tansley SL, Betteridge ZE, Shaddick G, Gunawardena H, Arnold K, Wedderburn LR, McHugh NJ, Juvenile Dermatomyositis Research Group.
    Rheumatology (Oxford); 2014 Dec; 53(12):2204-8. PubMed ID: 24987158
    [Abstract] [Full Text] [Related]

  • 12. Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?
    Valenzuela A, Chung L.
    J Scleroderma Relat Disord; 2022 Feb; 7(1):7-23. PubMed ID: 35386947
    [Abstract] [Full Text] [Related]

  • 13. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.
    Gunawardena H, Wedderburn LR, Chinoy H, Betteridge ZE, North J, Ollier WE, Cooper RG, Oddis CV, Ramanan AV, Davidson JE, McHugh NJ, Juvenile Dermatomyositis Research Group, UK and Ireland.
    Arthritis Rheum; 2009 Jun; 60(6):1807-14. PubMed ID: 19479859
    [Abstract] [Full Text] [Related]

  • 14. Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment.
    Pinotti CS, Cannon L, Dvergsten JA, Wu EY.
    Front Med (Lausanne); 2023 Jun; 10():1155839. PubMed ID: 36936211
    [Abstract] [Full Text] [Related]

  • 15. A systematic review of juvenile-onset clinically amyopathic dermatomyositis.
    Gerami P, Walling HW, Lewis J, Doughty L, Sontheimer RD.
    Br J Dermatol; 2007 Oct; 157(4):637-44. PubMed ID: 17596148
    [Abstract] [Full Text] [Related]

  • 16. Linear morphea with overlying lichen sclerosus and calcinosis cutis associated with juvenile dermatomyositis.
    Kaur M, Sadhukhan S, Bhardwaj A, Patra S, Rao M, Alam A.
    Pediatr Dermatol; 2023 Oct; 40(3):500-502. PubMed ID: 36384242
    [Abstract] [Full Text] [Related]

  • 17. Use of Janus kinase inhibitors in dermatomyositis: a systematic literature review.
    Paik JJ, Lubin G, Gromatzky A, Mudd PN, Ponda MP, Christopher-Stine L.
    Clin Exp Rheumatol; 2023 Mar; 41(2):348-358. PubMed ID: 35766013
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.